Item Type | Name |
Concept
|
Abnormalities, Drug-Induced
|
Concept
|
Acetaminophen
|
Concept
|
Acetylcysteine
|
Concept
|
Acetyltransferases
|
Concept
|
Acute-Phase Proteins
|
Concept
|
Adenosine Triphosphate
|
Concept
|
Adrenal Cortex Hormones
|
Concept
|
Adrenergic beta-Antagonists
|
Concept
|
Alcohol Dehydrogenase
|
Concept
|
Ethanol
|
Concept
|
Aldehyde Dehydrogenase
|
Concept
|
Aminoimidazole Carboxamide
|
Concept
|
Central Nervous System Stimulants
|
Concept
|
Analgesics
|
Concept
|
Analgesics, Opioid
|
Concept
|
Androgens
|
Concept
|
Androstadienes
|
Concept
|
Aniline Compounds
|
Concept
|
Antibodies, Anti-Idiotypic
|
Concept
|
Anti-Infective Agents
|
Concept
|
Anti-Infective Agents, Local
|
Concept
|
Anti-Infective Agents, Urinary
|
Concept
|
Anti-Inflammatory Agents
|
Concept
|
Anti-Ulcer Agents
|
Concept
|
Anti-Bacterial Agents
|
Concept
|
Antibiotics, Antineoplastic
|
Concept
|
Antibodies
|
Concept
|
Antibodies, Monoclonal
|
Concept
|
Anticoagulants
|
Concept
|
Anticonvulsants
|
Concept
|
Antidepressive Agents
|
Concept
|
Antiemetics
|
Concept
|
Antifungal Agents
|
Concept
|
Epitopes
|
Concept
|
Antigens
|
Concept
|
Antimetabolites
|
Concept
|
Antimetabolites, Antineoplastic
|
Concept
|
Antineoplastic Agents
|
Concept
|
Antioxidants
|
Concept
|
Antitussive Agents
|
Concept
|
Aryl Hydrocarbon Hydroxylases
|
Concept
|
Arylamine N-Acetyltransferase
|
Concept
|
Autoantibodies
|
Concept
|
Autoantigens
|
Concept
|
Baclofen
|
Concept
|
Base Sequence
|
Concept
|
Beclomethasone
|
Concept
|
Benzhydryl Compounds
|
Concept
|
Benzodiazepines
|
Concept
|
Binding Sites
|
Concept
|
Binding Sites, Antibody
|
Concept
|
Bronchodilator Agents
|
Concept
|
Buserelin
|
Concept
|
Caffeine
|
Concept
|
Calcium
|
Concept
|
Carbamazepine
|
Concept
|
Carbon Dioxide
|
Concept
|
Carbon Isotopes
|
Concept
|
Carboxylic Acids
|
Concept
|
Carboxylic Ester Hydrolases
|
Concept
|
Carrier Proteins
|
Concept
|
Catechol O-Methyltransferase
|
Concept
|
Ceftazidime
|
Concept
|
Cephalosporins
|
Concept
|
Child Development
|
Concept
|
Ciprofloxacin
|
Concept
|
Cisplatin
|
Concept
|
Clotrimazole
|
Concept
|
Clozapine
|
Concept
|
Codeine
|
Concept
|
Contraceptive Agents
|
Concept
|
Contraceptives, Oral
|
Concept
|
Cotinine
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Cytosine
|
Concept
|
Debrisoquin
|
Concept
|
Deferoxamine
|
Concept
|
Dehydroepiandrosterone
|
Concept
|
Delayed-Action Preparations
|
Concept
|
Drug Eruptions
|
Concept
|
Deuterium
|
Concept
|
Dexamethasone
|
Concept
|
Dextromethorphan
|
Concept
|
Dextrorphan
|
Concept
|
Dibenzazepines
|
Concept
|
Dicyclomine
|
Concept
|
Digoxin
|
Concept
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
|
Concept
|
Disulfides
|
Concept
|
Dithionitrobenzoic Acid
|
Concept
|
DNA
|
Concept
|
DNA, Fungal
|
Concept
|
DNA, Viral
|
Concept
|
Dosage Forms
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Doxylamine
|
Concept
|
Drug Administration Routes
|
Concept
|
Drug Administration Schedule
|
Concept
|
Drug Combinations
|
Concept
|
Drug Evaluation
|
Concept
|
Drug Hypersensitivity
|
Concept
|
Drug Industry
|
Concept
|
Drug Interactions
|
Concept
|
Drug Labeling
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Drug Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Pharmaceutical Preparations
|
Concept
|
Nonprescription Drugs
|
Concept
|
Environmental Pollutants
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Enzymes
|
Concept
|
Epoxide Hydrolases
|
Concept
|
Erythromycin
|
Concept
|
Esterases
|
Concept
|
Ethanolamines
|
Concept
|
Ethinyl Estradiol
|
Concept
|
Exons
|
Concept
|
Expectorants
|
Concept
|
Factor V
|
Concept
|
Fatty Acids, Unsaturated
|
Concept
|
Ferredoxin-NADP Reductase
|
Concept
|
Embryonic and Fetal Development
|
Concept
|
Fluoresceins
|
Concept
|
Fluorescent Dyes
|
Concept
|
Fluoxetine
|
Concept
|
Folic Acid
|
Concept
|
Folic Acid Antagonists
|
Concept
|
Gentamicins
|
Concept
|
Glucagon
|
Concept
|
Glucose
|
Concept
|
Glucuronates
|
Concept
|
Glutathione
|
Concept
|
Glutathione Reductase
|
Concept
|
Glutathione Transferase
|
Concept
|
Haptens
|
Concept
|
Heat-Shock Proteins
|
Concept
|
Histamine
|
Concept
|
Histamine Antagonists
|
Concept
|
HLA Antigens
|
Concept
|
Mixed Function Oxygenases
|
Concept
|
Hypnotics and Sedatives
|
Concept
|
Hypochlorous Acid
|
Concept
|
Immunoglobulin G
|
Concept
|
Imines
|
Concept
|
Immune Sera
|
Concept
|
Immunosuppressive Agents
|
Concept
|
Indoles
|
Concept
|
Indomethacin
|
Concept
|
Introns
|
Concept
|
Ionophores
|
Concept
|
Ions
|
Concept
|
Iron
|
Concept
|
Isoenzymes
|
Concept
|
Isoflavones
|
Concept
|
Isomerases
|
Concept
|
Ketoconazole
|
Concept
|
Peptidyl-Dipeptidase A
|
Concept
|
Lactones
|
Concept
|
Legislation, Drug
|
Concept
|
Lidocaine
|
Concept
|
Cholesterol, LDL
|
Concept
|
Luciferases
|
Concept
|
Membrane Glycoproteins
|
Concept
|
Methionine Sulfoximine
|
Concept
|
Methotrexate
|
Concept
|
Methylamines
|
Concept
|
Methyltransferases
|
Concept
|
Metoprolol
|
Concept
|
Metronidazole
|
Concept
|
Microfilament Proteins
|
Concept
|
Midazolam
|
Concept
|
Mitogens
|
Concept
|
Morphine
|
Concept
|
Morpholines
|
Concept
|
Muscle Relaxants, Central
|
Concept
|
Peroxidase
|
Concept
|
NAD
|
Concept
|
NADP
|
Concept
|
NADPH-Ferrihemoprotein Reductase
|
Concept
|
Naltrexone
|
Concept
|
Naphthalenes
|
Concept
|
Narcotic Antagonists
|
Concept
|
Neoplasm Proteins
|
Concept
|
Nicotine
|
Concept
|
Nitriles
|
Concept
|
Nitrobenzoates
|
Concept
|
Norgestrel
|
Concept
|
Omeprazole
|
Concept
|
Oxidoreductases
|
Concept
|
Oxidoreductases, N-Demethylating
|
Concept
|
Oximes
|
Concept
|
Oxycodone
|
Concept
|
Oxygenases
|
Concept
|
Peptide Fragments
|
Concept
|
Phenethylamines
|
Concept
|
Phenobarbital
|
Concept
|
Phenols
|
Concept
|
Phenyl Ethers
|
Concept
|
Phenytoin
|
Concept
|
Phosphodiesterase Inhibitors
|
Concept
|
Pimozide
|
Concept
|
Pirenzepine
|
Concept
|
Plasmids
|
Concept
|
Polyglutamic Acid
|
Concept
|
Prilocaine
|
Concept
|
Promoter Regions, Genetic
|
Concept
|
Propylamines
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Proteins
|
Concept
|
Proto-Oncogene Proteins
|
Concept
|
Pteroylpolyglutamic Acids
|
Concept
|
Pulmonary Surfactants
|
Concept
|
Pyridines
|
Concept
|
Pyridoxine
|
Concept
|
Quinidine
|
Concept
|
Receptors, Steroid
|
Concept
|
Receptors, Virus
|
Concept
|
Recombinant Proteins
|
Concept
|
Ribonucleotides
|
Concept
|
RNA
|
Concept
|
RNA, Messenger
|
Concept
|
Serotonin
|
Concept
|
Stereoisomerism
|
Concept
|
Steroid Hydroxylases
|
Concept
|
Sulfamethoxazole
|
Concept
|
Sulfates
|
Concept
|
Sulfonamides
|
Concept
|
Teratogens
|
Concept
|
Testosterone
|
Concept
|
Tetrahydrofolates
|
Concept
|
Tetrazolium Salts
|
Concept
|
Theophylline
|
Concept
|
Thiazoles
|
Concept
|
Thromboxane-A Synthase
|
Concept
|
Tobramycin
|
Concept
|
Tramadol
|
Concept
|
Antipsychotic Agents
|
Concept
|
Anti-Anxiety Agents
|
Concept
|
Transcription Factors
|
Concept
|
Transferases
|
Concept
|
Triglycerides
|
Concept
|
Trimethoprim
|
Concept
|
Biomarkers, Tumor
|
Concept
|
Glucuronosyltransferase
|
Concept
|
United States Food and Drug Administration
|
Concept
|
Valproic Acid
|
Concept
|
Nasal Decongestants
|
Concept
|
Vitamin D
|
Concept
|
Vitamin K
|
Concept
|
Vitamins
|
Concept
|
Warfarin
|
Concept
|
Xanthenes
|
Concept
|
Xanthine Oxidase
|
Concept
|
Drug Design
|
Concept
|
Zidovudine
|
Concept
|
Sulfotransferases
|
Concept
|
Arylsulfotransferase
|
Concept
|
Xenobiotics
|
Concept
|
Citalopram
|
Concept
|
Drugs, Investigational
|
Concept
|
Trimethoprim, Sulfamethoxazole Drug Combination
|
Concept
|
Gene Library
|
Concept
|
Mifepristone
|
Concept
|
Minor Histocompatibility Antigens
|
Concept
|
Free Radical Scavengers
|
Concept
|
Cytokines
|
Concept
|
Benzoquinones
|
Concept
|
Drug Delivery Systems
|
Concept
|
Drug Costs
|
Concept
|
Tacrolimus
|
Concept
|
Bupropion
|
Concept
|
NAD(P)H Dehydrogenase (Quinone)
|
Concept
|
Fluvoxamine
|
Concept
|
Program Development
|
Concept
|
Adverse Drug Reaction Reporting Systems
|
Concept
|
Pravastatin
|
Concept
|
Paroxetine
|
Concept
|
Investigational New Drug Application
|
Concept
|
Alternative Splicing
|
Concept
|
Receptors, Opioid, mu
|
Concept
|
DNA Primers
|
Concept
|
DNA, Complementary
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
Concept
|
Antirheumatic Agents
|
Concept
|
Gene Expression Regulation, Developmental
|
Concept
|
Antidepressive Agents, Second-Generation
|
Concept
|
Excitatory Amino Acid Antagonists
|
Concept
|
Antimanic Agents
|
Concept
|
Analgesics, Non-Narcotic
|
Concept
|
Adrenergic Uptake Inhibitors
|
Concept
|
Molecular Chaperones
|
Concept
|
CpG Islands
|
Concept
|
Anti-Allergic Agents
|
Concept
|
Anti-Asthmatic Agents
|
Concept
|
Anthracyclines
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Buthionine Sulfoximine
|
Concept
|
Lactic Acid
|
Concept
|
Cytochrome P-450 CYP1A1
|
Concept
|
Cytochrome P-450 CYP1A2
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Cytochrome P-450 CYP2E1
|
Concept
|
Protein Disulfide-Isomerases
|
Concept
|
Intramolecular Oxidoreductases
|
Concept
|
Simvastatin
|
Concept
|
Protective Agents
|
Concept
|
Tyrphostins
|
Concept
|
Protein Isoforms
|
Concept
|
Tandem Repeat Sequences
|
Concept
|
Cisapride
|
Concept
|
Response Elements
|
Concept
|
Sertraline
|
Concept
|
Glucuronides
|
Concept
|
DNA, Ribosomal Spacer
|
Concept
|
Tacrolimus Binding Proteins
|
Concept
|
RNA Splice Sites
|
Concept
|
Mitochondrial Proteins
|
Concept
|
E-Box Elements
|
Concept
|
Membrane Transport Proteins
|
Concept
|
Organic Anion Transporters
|
Concept
|
Multidrug Resistance-Associated Proteins
|
Concept
|
Organic Cation Transporter 1
|
Concept
|
Organic Anion Transporters, Sodium-Independent
|
Concept
|
Soybean Proteins
|
Concept
|
Steroid 16-alpha-Hydroxylase
|
Concept
|
Adolescent Development
|
Concept
|
Aldehyde Oxidase
|
Concept
|
Methylenetetrahydrofolate Reductase (NADPH2)
|
Concept
|
Carboxylesterase
|
Concept
|
Fetal Development
|
Concept
|
Retinoid X Receptors
|
Concept
|
Phytoestrogens
|
Concept
|
Serotonin Plasma Membrane Transport Proteins
|
Concept
|
Betaine-Homocysteine S-Methyltransferase
|
Concept
|
Wnt Proteins
|
Concept
|
Toll-Like Receptors
|
Concept
|
Toll-Like Receptor 2
|
Concept
|
Toll-Like Receptor 4
|
Concept
|
Aquaporin 1
|
Concept
|
Aquaporin 2
|
Concept
|
Cytochrome P-450 CYP3A
|
Concept
|
Hepatocyte Nuclear Factor 4
|
Concept
|
CCAAT-Enhancer-Binding Protein-delta
|
Concept
|
Oseltamivir
|
Concept
|
Janus Kinase 2
|
Concept
|
2-Pyridinylmethylsulfinylbenzimidazoles
|
Concept
|
Proton Pump Inhibitors
|
Concept
|
Nicotinamide Phosphoribosyltransferase
|
Concept
|
Drug Dosage Calculations
|
Concept
|
Lipocalins
|
Concept
|
Prescription Drugs
|
Concept
|
Antipyretics
|
Concept
|
Drug Overdose
|
Concept
|
Sulfonylurea Receptors
|
Concept
|
Vitamin K Epoxide Reductases
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
Concept
|
Cytochrome P-450 Enzyme Inhibitors
|
Concept
|
Cytochrome P-450 CYP1A2 Inhibitors
|
Concept
|
Cytochrome P-450 CYP1B1
|
Concept
|
Cytochrome P-450 CYP2A6
|
Concept
|
Cytochrome P-450 CYP2D6 Inhibitors
|
Concept
|
Cytochrome P-450 CYP3A Inhibitors
|
Concept
|
Cytochrome P-450 CYP2C9 Inducers
|
Concept
|
Cytochrome P-450 CYP2B6
|
Concept
|
Cytochrome P-450 CYP2C9
|
Concept
|
Cytochrome P-450 CYP2C19
|
Academic Article
|
Cytochrome P450 Involvement in the biotransformation of cisapride and racemic norcisapride in vitro: differential activity of individual human CYP3A isoforms.
|
Academic Article
|
Characterization of cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 activities toward model CYP2D6 substrates dextromethorphan, bufuralol, and debrisoquine.
|
Academic Article
|
Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites.
|
Academic Article
|
Fluorescence-based viability assay for studies of reactive drug intermediates.
|
Academic Article
|
Developmental and pediatric pharmacogenomics.
|
Academic Article
|
A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.
|
Academic Article
|
Developmental pharmacology--drug disposition, action, and therapy in infants and children.
|
Academic Article
|
Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro.
|
Academic Article
|
Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
|
Academic Article
|
Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
|
Academic Article
|
Development and refinement of pregnane X receptor (PXR) DNA binding site model using information theory: insights into PXR-mediated gene regulation.
|
Academic Article
|
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
|
Academic Article
|
A method for meta-analysis of epidemiological studies.
|
Academic Article
|
Ontogeny of drug metabolizing enzymes in the neonate.
|
Academic Article
|
Drug metabolite toxicity assessed in human lymphocytes with a purified, reconstituted cytochrome P-450 system.
|
Academic Article
|
Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.
|
Academic Article
|
Nuclear receptor expression in fetal and pediatric liver: correlation with CYP3A expression.
|
Academic Article
|
Effect of a triphasic oral contraceptive on drug-metabolizing enzyme activity as measured by the validated Cooperstown 5+1 cocktail.
|
Academic Article
|
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
|
Academic Article
|
CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.
|
Academic Article
|
Human anti-cytochrome P450 antibodies in aromatic anticonvulsant-induced hypersensitivity reactions.
|
Academic Article
|
Bendectin: the wrong way to regulate drug availability.
|
Academic Article
|
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565].
|
Academic Article
|
Biotransformation of fluticasone: in vitro characterization.
|
Academic Article
|
Expression and inducibility of antigens in severe combined immunodeficient mice recognized by human anti-P450 antibodies.
|
Academic Article
|
Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants.
|
Academic Article
|
Application of pharmacogenomic strategies to the study of drug-induced birth defects.
|
Academic Article
|
CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
|
Academic Article
|
Interindividual variability in acetaminophen sulfation by human fetal liver: implications for pharmacogenetic investigations of drug-induced birth defects.
|
Academic Article
|
Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.
|
Academic Article
|
Effect of counseling on maternal reporting of adverse effects in nursing infants exposed to antibiotics through breast milk.
|
Academic Article
|
Assessment of the impact of renal impairment on systemic exposure of new molecular entities: evaluation of recent new drug applications.
|
Academic Article
|
Personalized medicine: reality and reality checks.
|
Academic Article
|
Platform dependence of inference on gene-wise and gene-set involvement in human lung development.
|
Academic Article
|
Transcriptomic analysis of human lung development.
|
Academic Article
|
Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicology.
|
Academic Article
|
Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.
|
Academic Article
|
Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
|
Academic Article
|
Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.
|
Academic Article
|
Selective Toll--like receptor expression in human fetal lung.
|
Academic Article
|
The effect of genotype on methotrexate polyglutamate variability in juvenile idiopathic arthritis and association with drug response.
|
Academic Article
|
Developmental pharmacogenetics in pediatric rheumatology: utilizing a new paradigm to effectively treat patients with juvenile idiopathic arthritis with methotrexate.
|
Academic Article
|
Identifying genomic and developmental causes of adverse drug reactions in children.
|
Academic Article
|
Conference scene: pediatric pharmacogenomics and personalized medicine.
|
Academic Article
|
Genetic transmission of cytochrome P450 2D6 (CYP2D6) ultrarapid metabolism: implications for breastfeeding women taking codeine.
|
Academic Article
|
Developmental variations in metabolic capacity of flavin-containing mono-oxygenase 3 in childhood.
|
Academic Article
|
Expression analysis of asthma candidate genes during human and murine lung development.
|
Academic Article
|
NTP-CERHR expert panel report on the developmental toxicity of soy infant formula.
|
Academic Article
|
The role of CYP3A4 mRNA transcript with shortened 3'-untranslated region in hepatocyte differentiation, liver development, and response to drug induction.
|
Academic Article
|
Reversion of the SCID phenotype by human T cell grafts. Development of cross-species immunocompetence.
|
Academic Article
|
Development of biomarkers to optimize pediatric patient management: what makes children different?
|
Academic Article
|
Human anti-endoplasmic reticulum autoantibodies produced in aromatic anticonvulsant hypersensitivity reactions recognise rodent CYP3A proteins and a similarly regulated human P450 enzyme(s)
|
Academic Article
|
Interpreting pharmacogenetic data in the developing neonate: the challenge of hitting a moving target.
|
Academic Article
|
Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.
|
Academic Article
|
Trends in adverse reactions to trimethoprim-sulfamethoxazole.
|
Academic Article
|
Cotinine in human placenta predicts induction of gene expression in fetal tissues.
|
Academic Article
|
Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
|
Academic Article
|
Decreased expression of nicotinamide phosphoribosyltransferase in patients with juvenile idiopathic arthritis receiving methotrexate.
|
Academic Article
|
Age related changes in fractional elimination pathways for drugs: assessing the impact of variable ontogeny on metabolic drug-drug interactions.
|
Academic Article
|
Pharmacogenetics in pediatrics. Implications for practice.
|
Academic Article
|
Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line.
|
Academic Article
|
Epigenetic regulation of ADME-related genes: focus on drug metabolism and transport.
|
Academic Article
|
Vitamin D related genes in lung development and asthma pathogenesis.
|
Academic Article
|
Urinary biomarkers of trimethoprim bioactivation in vivo following therapeutic dosing in children.
|
Academic Article
|
Drug metabolism for the paediatrician.
|
Academic Article
|
VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
|
Academic Article
|
Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsy.
|
Academic Article
|
Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.
|
Academic Article
|
Individualizing the use of medications in children: making Goldilocks happy.
|
Academic Article
|
Glucocorticoid genes and the developmental origins of asthma susceptibility and treatment response.
|
Academic Article
|
Patients with delayed-onset sulfonamide hypersensitivity reactions have antibodies recognizing endoplasmic reticulum luminal proteins.
|
Academic Article
|
Acetaminophen overdose with therapeutic intent.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
|
Academic Article
|
Variability in Expression of CYP3A5 in Human Fetal Liver.
|
Academic Article
|
Genetic determinants of fetal opiate exposure and risk of neonatal abstinence syndrome: Knowledge deficits and prospects for future research.
|
Academic Article
|
Over-the-Counter Medications: Update on Cough and Cold Preparations.
|
Academic Article
|
In Vitro Hepatic Oxidative Biotransformation of Trimethoprim.
|
Academic Article
|
Development and Application of a High-Throughput Screening Method to Evaluate Antifungal Activity against Trichophyton tonsurans.
|
Academic Article
|
Age, Sexual Dimorphism, and Disease Associations in the Developing Human Fetal Lung Transcriptome.
|
Academic Article
|
Developmental Expression of CYP2B6: A Comprehensive Analysis of mRNA Expression, Protein Content and Bupropion Hydroxylase Activity and the Impact of Genetic Variation.
|
Academic Article
|
Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal Livers.
|
Academic Article
|
Decreased Pregnane X Receptor Expression in Children with Active Crohn's Disease.
|
Academic Article
|
Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.
|
Academic Article
|
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.
|
Academic Article
|
Challenges and Opportunities for Increasing the Knowledge Base Related to Drug Biotransformation and Pharmacokinetics during Growth and Development.
|
Academic Article
|
Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
|
Academic Article
|
Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver Microsomes.
|
Academic Article
|
Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.
|
Academic Article
|
Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs.
|
Academic Article
|
Age-dependent Protein Abundance of Cytosolic Alcohol and Aldehyde Dehydrogenases in Human Liver.
|
Academic Article
|
Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children With Cerebral Palsy.
|
Academic Article
|
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafine.
|
Academic Article
|
Cost and Potential Avoidability of Antibiotic-Associated Adverse Drug Reactions in Children.
|
Academic Article
|
Impact of SLCO1B1 Genotype on Pediatric Simvastatin Acid Pharmacokinetics.
|
Academic Article
|
Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.
|
Academic Article
|
Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice.
|
Academic Article
|
Glucuronidation in humans. Pharmacogenetic and developmental aspects.
|
Academic Article
|
Cellular toxicity of sulfamethoxazole reactive metabolites--I. Inhibition of intracellular esterase activity prior to cell death.
|
Academic Article
|
Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
|
Academic Article
|
Cytochrome P450 3A: ontogeny and drug disposition.
|
Academic Article
|
Acetaminophen intoxication during treatment: what you don't know can hurt you.
|
Academic Article
|
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
|
Academic Article
|
In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.
|
Academic Article
|
Aprepitant and fosaprepitant drug interactions: a systematic review.
|
Academic Article
|
Intensive and prolonged urine collection in preterm infants reveals three distinct indomethacin metabolic patterns: potential implications for drug dosing.
|
Academic Article
|
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
|
Academic Article
|
Glucagon therapy for beta-blocker overdose.
|
Academic Article
|
Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children's Hospital.
|
Academic Article
|
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity.
|
Academic Article
|
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.
|
Academic Article
|
Considerations for Implementing Precision Therapeutics for Children.
|
Academic Article
|
Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.
|
Academic Article
|
Optimization of gentamicin therapy in very low birth weight infants.
|
Academic Article
|
Developmental aspects of drug metabolism in children
|
Academic Article
|
Ontogeny of drug-metabolizing enzymes and its influence on the pathogenesis of adverse drug reactions in children
|
Academic Article
|
Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.
|
Academic Article
|
In: Handbook of Experimental Pharmacology Volume 121: Drug-Induced Hepatotoxicity. Cameron RG, Feuer G and de la Iglesia F, Eds
|
Academic Article
|
In: Metabolic Drug Interactions, Levy RH, Thummel KE, Trager WF, Hansten PD and Eichelbaum M, eds
|
Academic Article
|
In: Antiepileptic Drugs, 5th Edition, Levy RH et al, (Eds.)
|
Academic Article
|
In: Problems in Pediatric Drug Therapy, Fourth Edition, Pagliaro LA and Pagliaro AM (Eds)
|
Academic Article
|
In: Drug-Induced Liver Toxicity, 2nd Edition, Kaplowitz N and DeLeve L (Eds.)
|
Academic Article
|
Principles of Drug Administration in Children Receiving Renal Replacement Therapy Second Edition
|
Academic Article
|
In Biochemical and Molecular Basis of Pediatric Disease, 4th Ed., Wong E, Bennett M, and Dietzen D, eds
|
Academic Article
|
In: Drug-Induced Liver Toxicity, 3rd Edition, Kaplowitz N and DeLeve L (Eds.)
|
Academic Article
|
In: Textbook of Pediatric Rheumatology, Seventh Edition, Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, (Eds)
|
Academic Article
|
Who Believes They Are "Just Average": Informing the Treatment of Individual Patients Using Population Data.
|
Grant
|
2019 Drug Metabolism Gordon Research Conference Guiding Drug Development Using Translational ADME Science
|
Grant
|
Ontogeny and Genetics of NSAID Dose-Exposure Relationship in Preterm Infants
|
Grant
|
Clinical and Translational Mentored Career Development Award
|
Grant
|
Trimethoprim: an overlooked contributor of trimethoprim-sulfamethoxazole idiosyncratic adverse drug reactions
|
Academic Article
|
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
|
Academic Article
|
Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver.
|
Academic Article
|
The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
|
Academic Article
|
Functional Consequences of Pravastatin Isomerization on OATP1B1-Mediated Transport.
|
Academic Article
|
Effect of Intrauterine Smoke Exposure on microRNA-15a Expression in Human Lung Development and Subsequent Asthma Risk.
|
Academic Article
|
Recent advances in the ontogeny of drug disposition.
|
Academic Article
|
Ontogeny of Drug-Metabolizing Enzymes.
|
Academic Article
|
Ontogeny of Scaling Factors for Pediatric Physiology-Based Pharmacokinetic Modeling and Simulation: Microsomal Protein Per Gram of Liver.
|
Academic Article
|
The Impact of Age and Genetics on Naltrexone Biotransformation.
|
Academic Article
|
Interindividual Variability and Differential Tissue Abundance of Mitochondrial Amidoxime Reducing Component Enzymes in Humans.
|
Academic Article
|
Pediatric growth patterns in youth-onset type 2 diabetes mellitus: Implications for physiologically-based pharmacokinetic models.
|
Academic Article
|
Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective.
|
Grant
|
Ontogeny of drug transport
|
Grant
|
Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
|
Grant
|
Children’s Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
|
Grant
|
Effect of Obesity on Pantoprazole Pharmacokinetics and Pharmacodynamics in Children
|
Academic Article
|
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a Urinary Biomarker of Cytochrome P450 2D6 (CYP2D6) Activity.
|
Academic Article
|
Developmental pharmacokinetics of indomethacin in preterm neonates: Severely decreased drug clearance in the first week of life.
|
Academic Article
|
Ontogeny of Scaling Factors for Pediatric Physiologically Based Pharmacokinetic Modeling and Simulation: Cytosolic Protein Per Gram of Liver.
|
Academic Article
|
Sex and the Kidney Drug-Metabolizing Enzymes and Transporters: Are Preclinical Drug Disposition Data Translatable to Humans?
|
Academic Article
|
Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism.
|